Uday Bose MBA, MSc, BSc Econ (HONS)

Uday Bose is a highly experienced and successful leader in the life sciences sector, with over 25 years’ experience spanning General Management, market access, sales and marketing roles with National (UK/Ireland), Regional (EMEA) and Global accountability. He has significant speciality care experience, including all aspects of commercialisation for early and late-stage assets including 15 launches across 6 products. Since November 2022 Uday has returned to the Corporate Headquarters to lead the Global organisation for CXE and Business Steering. In this role he has accountability to ensure Boehringer Ingelheim is organised and has the right platforms, processes and capabilities in place to ensure the company can meet the current and future needs of the variety of partners they serve to ensure innovations reach patients who need them most. Prior to his current role, Uday held the position of Country Managing Director and Head of Human Pharma for Boehringer Ingelheim UK & Ireland between 2018 and 2022. Uday joined Boehringer Ingelheim in 2014 as Corporate Vice President/Head of Global Marketing, Therapeutic Area, Oncology. Uday has served as Chair of the European Medicines Group as well as a member of the Board of Directors of the Association of the British Pharmaceutical Industry. He has also served as an industry representative on the Appeal Panel of the National Institute for Care and Health Excellence (NICE). Uday graduated from Brunel University with degrees in MSc Finance & Investment (1998) and a BSc (Hons) Economics (1997). He obtained his MBA from Keele University in 2006 and is currently studying for his Doctorate Degree in Business at Durham University and emLyon Business School. He is also a guest lecturer and industry mentor for the University College of London Business School for Health.